Status:
COMPLETED
Blood Pressure Measurement: Should Technique Define Targets?
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypertension is the single most important risk factor for cardiovascular disease and death, yet blood pressure itself is highly influenced by technique and device. Hence, the target blood pressure cou...
Detailed Description
Hypertension is the single most important risk factor for cardiovascular disease and death. Over the last several decades many classes of blood pressure lowering drugs have been discovered. These allo...
Eligibility Criteria
Inclusion
- All patients being followed in the Renal Hypertension Clinic will be eligible for enrollment
Exclusion
- Inability to do oscillometric measures (eg., arrhythmia, pain, device reporting error)
- inability to consent the patient
Key Trial Info
Start Date :
October 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT03267420
Start Date
October 12 2017
End Date
August 31 2019
Last Update
March 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hypertension Unit of The Ottawa Hospital
Ottawa, Ontario, Canada, K1H 7W9